Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DIS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C1orf106 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX9-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM198B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMELY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC400655 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPT1P8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100631378 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHAF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCN8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLB1L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPV3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on